10 Endogenous GLP-1 causes peripheral food intake effects, including delay gastric emptying as well as reduction in gastrointestinal secretions and gastric mobility
External resources SURMOUNT-1 clinical trial results (New England Journal of Medicine) NIH National Institute of Diabetes and Digestive and Kidney Diseases In case I do not see you, good afternoon, good evening, and good night
Zepbound is a newer option with less clinical data, but semaglutide GLP-1 remains the most proven and effective for weight management
FDA-registered compounding pharmacies must follow strict pharmaceutical manufacturing requirements, pharmaceutical-grade semaglutide (the active ingredient) costs the same whether used in brand-name or compounded preparations, and testing for potency, sterility, and stability follows the same standards
I want people to know I've been there and I know your struggles